CGRP receptor antagonists
US10259812B2 · kind B2 · utility
2Cited by
26References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2017 |
| Grant date | Apr 16, 2019 |
| Priority date | — |
| Expiry date | Sep 19, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosures herein relate to novel compounds of formula wherein R1, R2 and R3 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.